SciSafe announced the expansion of its biorepository network in East Brunswick, highlighting New Jersey’s role as a cold storage powerhouse. The facility adds 5 million cubic feet of capacity and new freezers to meet increasing demand for temperature-controlled storage driven by biopharma innovation and healthcare logistics.

The strategic decision to expand in New Jersey offers same-day cold chain fulfillment and close proximity to major transportation routes. The facility’s GMP-compliant infrastructure and advanced inventory systems position it to support cutting-edge therapies like cell and gene treatments, emphasizing storage precision for sensitive biologics and pharmaceuticals.

New Jersey emerges as a competitive market for cold storage development, driven by rising consumer expectations and e-commerce grocery growth. The state’s “Three P’s” – Population, Production, and Ports – position it as an ideal location for cold storage facilities, with direct access to dense consumer markets and robust biopharma companies.

The Port of New York and New Jersey’s data underscore the region’s gateway scale, with millions of loaded containers passing through carrying perishable cargo. This demand fuels the development of nearby cold storage facilities that can efficiently handle cross-dock operations and maintain temperature integrity during transitions.

The surge in cold storage demand presents energy-intensive challenges requiring specialized talent and infrastructure. State agencies and educational institutions are responding with training programs to build expertise pipelines, ensuring the labor market evolves alongside infrastructure growth to meet the region’s logistical and life sciences needs.

Read more at Yahoo Finance: Why New Jersey’s cold storage surge matters for logistics